Business
JM Financial Predicts Up To 28 Percent Growth For Two Major Drug Companies
Reported by Rohit Yadav (Staff Writer) · Economic Times - Markets ·
Verified — Confirmed by a second source: Livemint - Markets
Confirmed by a second source: Livemint - Markets
Major
Representative image · PexelsJM Financial kept its buy ratings on Dr Reddy's Laboratories and Aurobindo Pharma after predicting a possible price rise of up to 28 percent over the next 12 months. The financial firm stated that better earnings growth, wider business setups, and new product releases will help both drug companies move forward in the market.
More in Business
BusinessVerified — Confirmed by a second source: Economic Times - MarketsMajor
Nasdaq and S&P 500 Climb as Market Awaits Federal Reserve Rate Call
Reported by Danish Ansari (Fact-Checker) · Google News - USA Business ·
